Literature DB >> 1984410

Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718.

C M Thumwood1, J Hong, G S Baldwin.   

Abstract

Specific cholecystokinin (CCK) receptor and gastrin receptor antagonists were used to assess what role, if any, these receptors have in autocrine cell growth. Although the cholecystokinin receptor antagonist, L-364,718, inhibited cell proliferation in a broad spectrum of cell lines, the gastrin antagonist, L-365,260, had no effect on cell proliferation. In addition neither added gastrin17, nor sulfated cholecystokinin8, could reverse the inhibitory action of L-364,718. It is proposed that L-364,718 inhibits cell proliferation independently of classical gastrin/CCK receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984410     DOI: 10.1016/0014-4827(91)90174-s

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Expression of gastrin, gastrin/CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas.

Authors:  A Imdahl; T Mantamadiotis; S Eggstein; E H Farthmann; G S Baldwin
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 2.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

3.  Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein.

Authors:  G S Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

Review 4.  Gastrin, gastrin receptors and colorectal carcinoma.

Authors:  G S Baldwin; A Shulkes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

5.  Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.

Authors:  M Blackmore; B H Hirst
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

6.  Evolution of a potential hormone antagonist following gene splicing during primate evolution.

Authors:  Cheng Deng; Aaron J W Hsueh
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.